Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T72684 | TLR7/8 agonist 7 | ||
TLR7/8 agonist 7 是一种 TLR7/8激动剂。TLR7/8 agonist 7 可激活多种免疫细胞,可用于合成抗体-免疫刺激偶联物 ISAC 分子。TLR7/8 agonist 7 可用于免疫的研究。 | |||
T5561 |
TLR7/8 agonist 1 dihydrochloride
TLR7/8 agonist-5d,二盐酸TLR7/8 agonist 1 |
TLR | Immunology/Inflammation |
TLR7/8 agonist 1 dihydrochloride (TLR7/8 agonist-5d) 是 toll 样受体TLR7/TLR8的双重激动剂。 | |||
T13167 |
TLR7/8 agonist 3
|
TLR | Immunology/Inflammation |
TLR7/8 agonist 3 是TLR7/8激动剂。 | |||
T39969 |
TLR7/8 agonist 4 TFA
|
||
TLR7/8 agonist 4 TFA (compound 41) is a highly potent TLR7/8 agonist that exhibits significant anti-cancer activity. | |||
T39968 |
TLR7/8 agonist 4 hydroxy-PEG10-acid
TLR7/8 agonist 4 hydroxy-PEG10-acid |
||
TLR7/8 agonist 4 hydroxy-PEG10-acid (compound 9) is a drug-linker conjugate employed in antibody-drug conjugates (ADC). This compound exhibits remarkable antitumor activity by utilizing TLR7/8 agonist 4, which acts as a potent activator of TLR7/8. The TLR7/8 agonist 4 is linked to hydroxy-PEG10-acid, the ADC linker, via a cleavable bond. Overall, it demonstrates promising pharmaceutical potential in the context of ADC-based therapeutics. | |||
T39970 |
TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride
TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride |
||
TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride (compound 9) is a drug-linker conjugate used in antibody-drug conjugates (ADCs) with high efficacy against tumors. It consists of TLR7/8 agonist 4, a potent TLR7/8 agonist, linked to the ADC linker hydroxy-PEG10-acid which can be cleaved. | |||
T79068 | TLR7/8 agonist 8 | ||
TLR7/8 agonist 8(compound 24m)是一种高效的TLR7/8双重激动剂,对hTLR7和hTLR8的EC50值分别为27 nM和12 nM。该化合物能增强PD-1/PD-L1阻断剂的抗癌效果。 | |||
T62177 |
TLR7/8 agonist 6
|
||
TLR7/8 agonist 6 (Compound 4) 是一种咪唑喹啉衍生物,是一种有效的 TLR7/8 激动剂,对 TLR7 和 TLR8 的 IC50 值分别为 0.18 和 5.34 μM。其中 Toll 样受体 (TLR) 7 和 8 是一种治疗传染病、癌症和自身免疫性疾病的免疫调节药物开发的关键靶点。 | |||
T79069 | TLR7/8 agonist 9 | ||
TLR7/8 agonist 9 (Compound 25a) 是一种能够增强PD-1/PD-L1阻断疗法抗肿瘤效果的化合物,主要用于癌症免疫疗法研究。它对hTLR7和hTLR8的EC50分别为40 nM和23 nM,显示出其对这两种受体的高亲和力以及潜在的抗肿瘤活性。 | |||
T60894 |
TLR7/8 agonist 4
|
||
TLR7/8 agonist 4 (compound 41) 是具有抗癌活性的,TLR7/8 的有效激动剂。 | |||
T64606 | TLR7/8 agonist-7d | ||
TLR7/8 agonist-7d 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T64606。 | |||
T71108 |
TLR7/8 agonist 1
|
||
TLR7/8 agonist 1是一种 toll 样受体 (TLR7)/TLR8的双重激动剂。 | |||
T80976 |
TLR7/8 agonist 4 hydroxy-PEG6-acid
|
||
TLR7/8 agonist 4hydroxy-PEG6-acid 为ADC药物-连接子偶联物(Drug-Linker Conjugates for ADC)。该合成物结合了TLR7/8 agonist 4与连接子hydroxy-PEG6-acid,专门用于ADC合成。 | |||
T77890 |
TLR7/8 agonist 4 hydroxy-PEG6-acid hydrochloride
|
||
TLR7/8 agonist 4hydroxy-PEG6-acid hydrochloride为一种用于抗体药物偶联体(ADC)的药物-连接子偶联物。该化合物为TLR7/8 agonist 4hydroxy-PEG6-acid的盐酸盐形式,由TLR7/8 agonist 4与连接子 Hydroxy-PEG6-acid构成,适用于ADC合成。 | |||
T17032 |
Telratolimod
MEDI9197,3M-052 |
TLR | Immunology/Inflammation |
Telratolimod (MEDI9197) 是TLR7/8的激动剂,具有抗肿瘤活性。 | |||
T6964 |
Resiquimod
R848,雷西莫特,S28463 |
HCV Protease; TLR | Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
Resiquimod (R848) 是一种 Toll 样受体7/8的激动剂,可诱导细胞因子上调。 | |||
T62178 | TLR7/8 antagonist 1 | ||
TLR7/8 Antagonist 1 (Compound 16c) 是一种咪唑喹啉衍生物,是一种有效的 TLR7/8 激动剂,对 TLR7 和 TLR8 的 IC50 值分别为 3.91 和 2.19 μM。其中 Toll 样受体 (TLR) 7 和 8 是一种治疗传染病、癌症和自身免疫性疾病的免疫调节药物开发的关键靶点。 |